pubmed.ncbi.nlm.nih.gov

Trends in snakebite envenomation therapy: scientific, technological and public health considerations - PubMed

Review

Trends in snakebite envenomation therapy: scientific, technological and public health considerations

José María Gutiérrez et al. Curr Pharm Des. 2007.

Abstract

The therapy of snakebite envenomation has been based on the parenteral administration of animal-derived antivenoms. Despite the success of this treatment at reducing the impact of snakebite mortality and morbidity, mostly due to their capacity to neutralize systemically-acting toxins, antivenoms are of relatively low efficacy in the prevention of venom-induced local tissue damage, which often leads to permanent disability. The issue of safety also remains a concern, particularly for some antivenoms which induce a relatively high incidence of adverse reactions. Consequently, there is a need to improve the therapy of snakebite envenomations on the following lines: (a) the technologies to produce antivenoms require improvements aimed at obtaining more refined preparations of higher efficacy and safety, while being affordable for the public health systems of developing countries. (b) The growing knowledge on the biochemistry and toxicology of snake venoms should pave the way for the identification of natural and synthetic inhibitors of venom toxins, particularly of those involved in local tissue pathology. Such inhibitors might become a highly effective therapeutic tool for the abrogation of venom-induced local tissue damage. (c) A better knowledge of the inflammatory events secondary to venom actions may open the possibility of modulating such response, in order to prevent further tissue damage and to promote successful tissue repair and regeneration. A global partnership, involving many participants and combining scientific, technological and public health actions, is required to achieve a leap forward in the treatment of snakebite envenomations world-wide.

PubMed Disclaimer

Cited by

Snake bite in South Asia: a review.
Alirol E, Sharma SK, Bawaskar HS, Kuch U, Chappuis F. Alirol E, et al. PLoS Negl Trop Dis. 2010 Jan 26;4(1):e603. doi: 10.1371/journal.pntd.0000603. PLoS Negl Trop Dis. 2010. PMID: 20126271 Free PMC article. Review.
Snake venom PLA2s inhibitors isolated from Brazilian plants: synthetic and natural molecules.
Carvalho BM, Santos JD, Xavier BM, Almeida JR, Resende LM, Martins W, Marcussi S, Marangoni S, Stábeli RG, Calderon LA, Soares AM, Da Silva SL, Marchi-Salvador DP. Carvalho BM, et al. Biomed Res Int. 2013;2013:153045. doi: 10.1155/2013/153045. Epub 2013 Sep 22. Biomed Res Int. 2013. PMID: 24171158 Free PMC article. Review.
In vitro assessment of cytotoxic activities of Lachesis muta muta snake venom.
Stransky S, Costal-Oliveira F, Lopes-de-Souza L, Guerra-Duarte C, Chávez-Olórtegui C, Braga VMM. Stransky S, et al. PLoS Negl Trop Dis. 2018 Apr 16;12(4):e0006427. doi: 10.1371/journal.pntd.0006427. eCollection 2018 Apr. PLoS Negl Trop Dis. 2018. PMID: 29659601 Free PMC article.
Prospecting Local Treatments Used in Conjunction with Antivenom Administration Following Envenomation Caused by Animals: A Systematic Review.
Carvalho ÉS, Oliveira I, Nascimento TP, da Silva Neto AV, Leal BAS, Araújo FQ, Julião BFV, Souza ARN, Abrahim AW, Macedo BBO, de Oliveira JTS, Wen FH, Pucca MB, Monteiro WM, Sachett JAG. Carvalho ÉS, et al. Toxins (Basel). 2023 Apr 28;15(5):313. doi: 10.3390/toxins15050313. Toxins (Basel). 2023. PMID: 37235348 Free PMC article. Review.
Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead.
Gutiérrez JM, Solano G, Pla D, Herrera M, Segura Á, Vargas M, Villalta M, Sánchez A, Sanz L, Lomonte B, León G, Calvete JJ. Gutiérrez JM, et al. Toxins (Basel). 2017 May 13;9(5):163. doi: 10.3390/toxins9050163. Toxins (Basel). 2017. PMID: 28505100 Free PMC article. Review.

Trends in snakebite envenomation therapy: scientific, technological and public health considerations - PubMed